Increasing adoption of SUBs among small companies and startups, ease in the cultivation of marine organisms, reduced energy and water consumption, reduced automation complexity, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are factors driving the growth of this market.
According to research report Single use Bioreactors Market is projected to reach $8.8 billion by 2026, at a CAGR of 21.1% during the forecast period.
The single-use bioreactor systems segment dominated the market in 2020. Based on product, the single-use bioreactors market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others. SUB systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharma applications.
The stirred-tank SUBs segment dominated the single-use bioreactors market in 2020. Based on type, the single-use bioreactors market is categorized into wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors such as hybrid bioreactors and SUBs with vertically perforated discs. The stirred-tank SUBs are highly preferred in the cultivation of aerobic microbial cultures as it promote greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.
The prominent players operating in the single use bioreactors market are Sartorius Stedim Biotech (France), Danaher Corporation (US), Thermo Fisher Scientific (US) and Merck KGaA (Germany).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750